ArticleMedical oncology (Northwood, London, England)2022

Targeting MDC1 promotes apoptosis and sensitizes Imatinib resistance in CML cells by mainly disrupting non-homologous end-joining repair.

Yang Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.